Hyderabad, 1 Jan 2024: Gangadi Madhukar Reddy, Managing Director and CEO of Medplus Health Services does not expect any material impact from the recent suspension of drug licence of one of the company's subsidiary.

 

Related News

• Indian Patent Office to hear objections on Gilead's HIV drug patent claims (18-09-2024)

---

• CDSCO revises guidance document for functions & responsibilities of zonal, sub-zonal & port offices (18-09-2024)

---

• India exported drugs and pharma worth $11.9 bn in April-August 2024 (18-09-2024)

---

• US FDA releases draft guidance on oncology multiregional clinical trials (18-09-2024)

---

• Narcotists raid in UP-Uttarakhand, fake medicines worth three crores, machines worth eight crores seized, five arrested (18-09-2024)

---

• DCC recommends making Sugam portal database of all products with brand names (17-09-2024)

---

• CDSCO releases draft guidelines on good clinical practices for consultation (17-09-2024)

---

• One-third of India’s 30 lakh sepsis deaths linked to antimicrobial resistance (17-09-2024)

---

• Pharmacist practicing without degree, 35 types of medicines and surgical equipments seized (17-09-2024)

---

• CDSCO to switch Form 44 submission online (16-09-2024)

---